Inherited thrombotic disorders: An update
- 1 January 1997
- journal article
- review article
- Published by Wiley in American Journal of Hematology
- Vol. 54 (1) , 53-60
- https://doi.org/10.1002/(sici)1096-8652(199701)54:1<53::aid-ajh8>3.0.co;2-3
Abstract
Significant advances in identification of etiologies of inherited thrombosis have been recently reported. A point mutation in coagulation factor V (factor V Leiden) results in resistance to activated protein C and probably represents the most common genetic risk factor for venous thrombosis. A metabolic disorder, homocysteinemia, is now known to be an important risk factor for both arterial and venous thrombosis. Many patients with recurrent thrombosis will have more than one genetic risk factor identified. Recognition of these new disorders should permit a diagnosis to be achieved in at least half of patients evaluated for inherited thrombosis. Am. J. Hematol. 54:53–60, 1997Keywords
This publication has 33 references indexed in Scilit:
- Hyperhomocysteinemia as a Risk Factor for Deep-Vein ThrombosisNew England Journal of Medicine, 1996
- Evidence for a single origin of factor V LeidenBritish Journal of Haematology, 1996
- Risk of thrombosis in patients homozygous for factor V Leiden [letter; comment]Blood, 1995
- Is hyperhomocysteinaemia a risk factor for recurrent venous thrombosis?The Lancet, 1995
- Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutationThe Lancet, 1994
- Mutation in blood coagulation factor V associated with resistance to activated protein CNature, 1994
- Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia StudyThe Lancet, 1993
- Anticoagulant protein C pathway defective in majority of thrombophilic patients [see comments]Blood, 1993
- Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C.Proceedings of the National Academy of Sciences, 1993
- The protein C anticoagulant pathway.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1992